Fosun International LTD Curis Inc Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.74 - $2.83 $1.01 Million - $1.65 Million	-581,834 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$1.36 - $2.35 $251,552 - $434,667	184,965 Added 46.61%	581,834 $1.07 Million
Q1 2019 May 10, 2019	BUY	$0.78 - $2.01 $152,710 - $393,523	195,783 Added 97.36%	396,869 $762,000
Q4 2018 Jan 31, 2019	BUY	$0.62 - $2.25 $124,673 - $452,443	201,086 New	201,086 $149,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.